Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Active
HT942627QE003Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Army Medical Resources Acquisition Activity is soliciting a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1. To maintain FDA approval and operational requirements, the contractor must provide original manufacturer-supplied consumables, as no generic substitutes are available. Required supplies include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, and ACD-A Solution. The contract is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS code 325413. The BPA features a cumulative ceiling not to exceed 350,000 dollars over a 60-month ordering period, with individual call orders typically having a 12-month period of performance. Award will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as either acceptable or unacceptable. Offerors must submit a two-volume quote by October 29, 2026, using the mandatory Exhibit A Pricing Sheet. Delivery is FOB Destination to Fort Sam Houston, Texas, and invoicing must be processed through the Wide Area WorkFlow system.

General Info

BPA for manufacturer-supplied consumables for Terumo blood collection systems at Fort Sam Houston.

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

0, TX, 78234, USA

Set-Aside

SDVOSBC

Documents

3

Amendment 0001 to Solicitation HT942627QE0030001

PDF, High priority: read this firstamendment
High

RFQ HT942627QE0030001 - Consumable supplies for Terumo Trima Acel blood collection systems

PDF, High priority: read this firstrfq
High

Solicitation HT942627QE003 - Consumable supplies for Terumo Trima Accel

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Army Medical Resources Acq Activity
Contacts2 people available
OfficeFORT DETRICK, MD, 21702, USA
Office AddressFORT DETRICK, MD, 21702, USA
Contacts
Jeremy McMurry
Eric Zampelli

Full Description

Show more

See Soliciation Amendment 0001.


USAISR's Combat Casualty Care Research Team 1 (CRT-1) requires resupply of its Blood Donor Room on a reoccurring basis in order to satisfy research requirements for blood collection. USAISR currently has three Terumo Trima Accel Blood Collection Systems in operation. These units support numerous research protocols. Various collection sets are used to collect a variety of blood products from donors. The Trima instrument is FDA-approved, but only with the use of original manufacturer-supplied consumable products. These consumables are specific to the instrument and there are no generic substitute products available in the marketplace.
 


Please note - This is a 100% ser-aside for Service-Disabled Veteran-Owned Small Businesses.


See attached complete solicitation for all requirement details and instructions to offerors.



Similar Contracts

Same NAICS industry code

NAICS: 325413
New
Federal
6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Solicitation # 36C26227Q0046
The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.
262-NETWORK Contract Office 22 (36C262)

POSTED

2 days ago

DEADLINE

in 14 days
View Details

More opportunities from Department Of Defense → Army Medical Resources Acq Activity

Same awarding agency

NAICS: 541715
New
Federal
Mild Traumatic Brain Injury (mTBI) Blast Injury Prevention Standards Request for Information
Solicitation # CB4_SW_mTBI_RFI
The Army Medical Resources Acq Activity, specifically the USAMRDC and the Department of War Blast Injury Research Coordinating Office in collaboration with The MITRE Corporation, has issued a Request for Information regarding Mild Traumatic Brain Injury blast injury prevention standards. This initiative aims to identify existing and emerging injury criteria, thresholds, standards, and models to inform the Military Health System Blast Injury Prevention Standards Recommendation process. The primary goal is to gather biomedically valid data, such as dose response curves and injury thresholds, to improve health hazard assessments, survivability assessments, and the development of protection systems for service members exposed to explosive weapons. This notice is issued solely for information and program planning purposes and does not constitute a formal solicitation for proposals. In accordance with FAR 15.201(e), responses are not considered offers and cannot be accepted to form a binding contract, nor will the government provide reimbursement for costs associated with participating. Interested parties from industry, academia, and other federal agencies are encouraged to submit relevant publications, reports, and images through a specific online submission process. The primary point of contact for this effort is Contract Specialist Skylar Wells, and the response deadline is November 3, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 14 days
View Details
NAICS: 541330
Federal
Independent Commissioning Agent (Owner’s Advocate) Services for U.S. Army Medical Research Institute of Infectious Diseases
Solicitation # EMO-26-0001
The Defense Health Agency Contracting Activity is seeking information for an independent third-party Commissioning Agent to serve as an Owner's Advocate for the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick, Maryland. The primary objective is to bridge the technical gap between the U.S. Army Corps of Engineers and the end-user to facilitate the transition of Building 8100 into functional occupancy. This state-of-the-art replacement facility, which spans 835,000 gross square feet, includes critical BSL-3 and BSL-4 maximum containment laboratories, a vivarium, and complex mechanical support systems. The agent will be responsible for verifying critical facility systems, witnessing failure-scenario testing to ensure zero airflow reversals, and providing regulatory compliance support for Federal Select Agent Program registration under 42 CFR Part 73. The anticipated contract is a non-severable 60-month period of performance, likely structured as a Firm-Fixed-Price contract with performance-based milestone payments. Key requirements include a regular on-site presence and the provision of various technical deliverables, such as technical review memos, sterilization validation plans, and monthly progress reports. To ensure impartiality, the contractor must certify organizational independence and have no conflicting roles with the prime construction contractors. The government is currently evaluating market capabilities to determine if the requirement can be set aside for small businesses under NAICS code 541330 and is considering the use of oral presentations for the final technical evaluation process.
Engineering Services

POSTED

11 days ago

DEADLINE

in 20 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS